This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Over the past decade, macro trends in healthcare have pushed life sciences companies to pursue increasingly sophisticated keyaccountmanagement (KAM) strategies and capabilities to provide unique offerings and value. As a consequence, pharma companies will need to rethink team sizing and resource allocation to accounts.
The three new European hires are: Maria Lehretz, Medical Director, Velocity Leipzig, Germany Maria has nearly a decade of experience as a clinical research physician, and has worked on approximately 70 clinical trials. She has 20 years’ experience in business development and keyaccountmanagement in the clinical trials arena.
The product was then targeted to specific physicians and dispensed to pharmacies. A survey conducted by Cegedim revealed that KeyAccountManagement (KAM) was the technique that procured the best results for market access strategies. Thus, market access involved little engagement with a small set of stakeholders.In
The product was then targeted to specific physicians and dispensed to pharmacies. A survey conducted by Cegedim revealed that KeyAccountManagement (KAM) was the technique that procured the best results for market access strategies. Thus, market access involved little engagement with a small set of stakeholders.In
Instead of a limited focus on creating product awareness and communicating product benefits, leading Sales Reps and KeyAccountManagers have a stringent focus on improving the customer value and experience. You have to maximize every single human moment that you get in front of the physician.
Networking Skills: Actively networking within the healthcare industry enables sales reps to establish and nurture relationships with key stakeholders, including physicians, nurses, administrators, and purchasing managers. Sales reps must demonstrate honesty, integrity, and reliability in all interactions.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content